Oxaliplatin With Radiotherapy More Efficacious on Rectal Cancer Than Fluorouracil

Share this content:
Oxaliplatin-based preoperative chemoradiotherapy may yield more pathological complete responses for locally-advanced rectal cancer.
Oxaliplatin-based preoperative chemoradiotherapy may yield more pathological complete responses for locally-advanced rectal cancer.

Oxaliplatin-based preoperative chemoradiotherapy may yield more pathological complete responses (pCR) than fluorouracil-based therapy for patients with locally-advanced rectal cancer, according to a study published in the Journal of Clinical Oncology.1

In this 3-armed, randomized, phase 3 study, researchers evaluated whether oxaliplatin raises the likelihood of pCR with or without radiation, in comparison to fluorouracil.

A total of 495 patients were enrolled, of which 475 were evaluable; 155 received fluorouracil-radiotherapy, 157 received oxaliplatin-radiotherapy, and 163 received oxaliplatin only.

Among the 3 groups, pCR rates were: 14.0%, 27.5%, and 6.6% for fluorouracil-radiotherapy, oxaliplatin-radiotherapy, and oxaliplatin only, respectively; down-staging rates were 37.1%, 56.4%, and 35.5%, respectively.

RELATED: Some Patients With Locally Advanced Rectal Cancer May Avoid Surgery

The authors concluded that oxaliplatin-radiotherapy yielded the best pathological results, though oxaliplatin only led to similar down-staging results as fluorouracil-radiotherapy, yet without the radiation-associated complications and toxicities.

Reference

  1. Deng Y, Chi P, Lan P, et al. Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial. J Clin Oncol. 2016 Aug 1. doi: 10.1200/JCO.2016.66.6198 [Epub ahead of print]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters